Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nancy M. Klinger"'
Publikováno v:
Chest. 115:945-951
Background Chlorofluorocarbons (CFCs) used as propellants in metered-dose inhalers deplete stratospheric ozone, which results in serious public health concerns. Albuterol has been reformulated in the non-ozone-depleting propellant, hydrofluoroalkane-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e48887d05ea9d9f74b43412b4c62b0a1
https://doi.org/10.1378/chest.115.4.945
https://doi.org/10.1378/chest.115.4.945
Publikováno v:
Journal of Asthma. 36:671-676
Short-acting inhaled beta2-agonists used just prior to exercise are an effective method for preventing exercise-induced bronchoconstriction (EIB) in children. This was a randomized, single-blind, placebo-controlled, four-period crossover study that c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f5aed5df24cba90b95c4958943fda24
https://doi.org/10.3109/02770909909055419
https://doi.org/10.3109/02770909909055419
Publikováno v:
Annals of Allergy, Asthma & Immunology. 81:593-599
As a result of the pending ban on chlorofluorocarbon production, the non-chlorofluorocarbon propellant 1,1,1,2-tetrafluoroethane (HFA-134a) is being evaluated as a replacement for CFCs in metered-dose inhalers.This cumulative dose response study comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e85a13c7a487699bac3714c891fd42
https://doi.org/10.1016/s1081-1206(10)62711-1
https://doi.org/10.1016/s1081-1206(10)62711-1
Autor:
Kent Letourneau, Daniel E Wagner, Gina L Burgess, Gene L. Colice, Robert J. Dockhorn, Nancy M. Klinger, Kerry B Hafner
Publikováno v:
Annals of Allergy, Asthma & Immunology. 79:85-88
Introduction During the 1970s, scientists suggested that the growing use of chlorofluorocarbons (CFCs) was contributing to depletion of the stratospheric ozone layer with potentially harmful results. A committee on the ozone layer organized the prepa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85266f2843c337f9786b1dcdd243e335
https://doi.org/10.1016/s1081-1206(10)63091-8
https://doi.org/10.1016/s1081-1206(10)63091-8
Publikováno v:
The Journal of asthma : official journal of the Association for the Care of Asthma. 37(8)
This was an open-label, parallel group, randomized, age-stratified, multicenter study designed to compare the safety and efficacy of regular use of albuterol formulated in hydrofluoroalkane-134a (HFA albuterol) and albuterol formulated in chlorofluor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b228e8ac0bf0787ef6f93305528af981
https://pubmed.ncbi.nlm.nih.gov/11192231
https://pubmed.ncbi.nlm.nih.gov/11192231
Publikováno v:
The Journal of asthma : official journal of the Association for the Care of Asthma. 36(1)
Chlorofluorocarbon (CFC) propellants deplete stratospheric ozone. Production and use of CFCs, except for certain critical exemptions, has been prohibited by the Montreal Protocol. Use of CFCs as propellants in metered-dose inhalers (MDIs) is still al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262ba57bf8b4dacf5010ced36b157186
https://pubmed.ncbi.nlm.nih.gov/10077140
https://pubmed.ncbi.nlm.nih.gov/10077140
Autor:
Joe W. Ramsdell, Nancy M. Klinger, Bruce P. Ekholm, Gene L. Colice, Herbert B. Slade, Eugene R. Bleecker, David G. Tinkelman
Publikováno v:
Chest. 113(2)
Objective To compare the bronchodilator effectiveness of albuterol reformulated in the chlorofluorocarbon-free propellant hydrofluoroalkane (HFA) 134a (Proventil HFA) to that of Ventolin and HFA placebo over 12 weeks of regular dosing. Design Randomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9a9a5719b789aa333c8def186920789
https://pubmed.ncbi.nlm.nih.gov/9498940
https://pubmed.ncbi.nlm.nih.gov/9498940
Autor:
Herbert B. Slade, Bruce P. Ekholm, Eugene R. Bleecker, David G. Tinkelman, Gene L. Colice, Joe W. Ramsdell, Nancy M. Klinger
Publikováno v:
Chest. 113(2)
Objective As a secondary objective to a long-term study evaluating the bronchodilator effectiveness of Proventil HFA (albuterol), to assess the safety of Proventil HFA, Ventolin, and hydrofluoroalkane 134a (HFA-134a) placebo over 12 weeks of regular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4131850c3147a2f2f48564b43503592
https://pubmed.ncbi.nlm.nih.gov/9498941
https://pubmed.ncbi.nlm.nih.gov/9498941
Autor:
Sally E. Mccarville, Nancy M. Klinger, Karen A. Wick, Shaw F. Chang, Amit K. Mitra, James C. Kisicki, Dockhorn Rj, Steve M. Berge, Colin R. Kehe, Kathy M. Cooper, Lester I. Harrison, Patrick J. Roddy
Publikováno v:
Journal of pharmaceutical sciences. 82(6)
Two three-way crossover studies were done to characterize the drug release characteristics of Monospan (3M Pharmaceuticals, St. Paul, MN) capsules, a new once-a-day theophylline formulation. In the first study, 22 healthy males received single 450-mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efd8607a65c411207aa393d45fbd8525
https://pubmed.ncbi.nlm.nih.gov/8331541
https://pubmed.ncbi.nlm.nih.gov/8331541